James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

JD vs. BABA: Is JD.Com Inc(ADR) or Alibaba Group Holding Ltd the Better Buy?

JD.Com (JD) and Alibaba Group Holding (BABA) are starting to gel, but one of these e-commerce names has the advantage.

Why Barclays PLC (ADR) (BCS), Barrick Gold Corporation (USA) (ABX) and Medtronic PLC (MDT) Are 3 of Today’s Worst Stocks

Tuesday's strength didn't do Barclays (BCS), Barrick Gold (ABX) and Medtronic (MDT) a bit of good. Here's the deal.

Valeant Pharmaceuticals Intl Inc (VRX): Don’t Go Bottom-Fishing in a Polluted Lake

VRX stock isn't just the victim of a little volatility: The past six months have exposed fundamental flaws in every aspect of Valeant Pharmaceuticals' business model.

Walt Disney Co: Theme Park Price Hike Won’t Kill DIS Stock

Walt Disney didn't make any new friends this week with a new pricing scheme, but Disney stock isn't in any real trouble.

Berkshire Hathaway Inc. (BRK.A, BRK.B) Is Still a Simple, No-Brainer Buy

Warren Buffett has done it again, proving Berkshire Hathaway (BRK.B, BRK.A) looks like a collection of cash-driving businesses you'd buy yourself to run.